2005
DOI: 10.1111/j.1365-2559.2005.02182.x
|View full text |Cite
|
Sign up to set email alerts
|

Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours

Abstract: NANOG is a new marker for testicular CIS and germ cell tumours and the high level of NANOG along with OCT-4 are determinants of the stem cell-like pluripotency of the preinvasive CIS cell. Timing of NANOG down-regulation in fetal gonocytes suggests that NANOG may act as a regulatory factor up-stream to OCT-4.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
140
1
7

Year Published

2006
2006
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 200 publications
(158 citation statements)
references
References 34 publications
10
140
1
7
Order By: Relevance
“…Postnatally, the expression of NANOG persisted in marmosets until the neonatal period, whereas individual OCT4+ and TFAP2C+ cells were observed until 6 weeks after birth (Mitchell et al, 2008). These findings are in agreement with a previous report indicating that downregulation of NANOG precedes that of OCT4 (Hoei-Hansen et al, 2005). Histological evaluation of neonatal human testes revealed comparable OCT4 expression pattern (Mitchell et al, 2008;Reijpert-de Meyts et al, 2004).…”
Section: Comparative Expression Analysis In Primordial and Perinatal supporting
confidence: 91%
“…Postnatally, the expression of NANOG persisted in marmosets until the neonatal period, whereas individual OCT4+ and TFAP2C+ cells were observed until 6 weeks after birth (Mitchell et al, 2008). These findings are in agreement with a previous report indicating that downregulation of NANOG precedes that of OCT4 (Hoei-Hansen et al, 2005). Histological evaluation of neonatal human testes revealed comparable OCT4 expression pattern (Mitchell et al, 2008;Reijpert-de Meyts et al, 2004).…”
Section: Comparative Expression Analysis In Primordial and Perinatal supporting
confidence: 91%
“…Ectopic expression of Nanog leads to dedifferentiation and blocks further developmental processes (Taranger et al, 2005). Malignant transformation of teratocarcinomas and germline tumors are caused by ectopic expression of Nanog (Almstrup et al, 2004;Hoei-Hansen et al, 2005;Skotheim et al, 2005). Overexpression of the full-length retrogene Nanog P8 has been identified in a large variety of different solid tumors or cancer cell lines .…”
Section: Discussionmentioning
confidence: 99%
“…However, most of these studies focused on pluripotency genes that were also retained in carcinoma in situ and TGCTs. Typical examples are the transcription factors NANOG, OCT4, TFAP2C (AP2g), and the miRNA-binding protein LIN28A, which are expressed not only in rodent and human fetal PGCs and gonocytes (Culty 2009, Weber et al 2010, but also in testicular tumors (Hoei-Hansen et al 2005, Rajpert-De Meyts 2006, Sonne et al 2009, Gillis et al 2011, Aeckerle et al 2012. In mouse and human ESCs, both NANOG and OCT4 were found to belong to a protein network regulating cell pluripotency, which included also Wnt and its downstream target b-catenin (AbuRemaileh et al 2010, Marucci et al 2014.…”
Section: Insights From Non-rodent Speciesmentioning
confidence: 99%